Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-16-004559
Filing Date
2016-04-08
Accepted
2016-04-08 16:32:21
Documents
8
Period of Report
2016-05-26
Effectiveness Date
2016-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A axgn-20160526xdef14a.htm DEF 14A 1085475
2 GRAPHIC axgn20160526xdef14a001.jpg GRAPHIC 25124
3 GRAPHIC axgn20160526xdef14a002.gif GRAPHIC 70714
4 GRAPHIC axgn20160526xdef14a003.gif GRAPHIC 44822
5 GRAPHIC axgn20160526xdef14a004.gif GRAPHIC 40140
6 GRAPHIC axgn20160526xdef14a005.gif GRAPHIC 70086
7 GRAPHIC axgn20160526xdef14a006.gif GRAPHIC 27356
8 GRAPHIC axgn20160526xdef14a007.gif GRAPHIC 3223
  Complete submission text file 0001558370-16-004559.txt   1475197
Mailing Address 13859 PROGRESS BLVD. SUITE 100 ALACHUA FL 32615
Business Address 13859 PROGRESS BLVD. SUITE 100 ALACHUA FL 32615 (386) 462-6817
AxoGen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36046 | Film No.: 161563020
SIC: 3845 Electromedical & Electrotherapeutic Apparatus